Arcutis Biotherapeutics (ARQT) News Today $17.38 0.00 (0.00%) Closing price 04:00 PM EasternExtended Trading$17.40 +0.02 (+0.09%) As of 07:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ARQT Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Arcutis Biotherapeutics (NASDAQ:ARQT) Stock Price Up 4.5% - What's Next?September 18, 2025 | marketbeat.comTriumph Capital Management Takes Position in Arcutis Biotherapeutics, Inc. $ARQTSeptember 18, 2025 | marketbeat.comArcutis Biotherapeutics announces new Zoryve data at EADV congressSeptember 17, 2025 | msn.comArcutis To Present Multiple New ZORYVE® (roflumilast) Data Analyses at European Academy of Dermatology and Venereology CongressSeptember 17, 2025 | globenewswire.comArcutis Biotherapeutics’ ZORYVE Wins 2025 Allure Best of Beauty Breakthrough Award for Innovation in DermatologySeptember 16, 2025 | quiverquant.comQAllure Magazine Honors Arcutis' ZORYVE® (roflumilast) with Prestigious Best of Beauty Breakthrough AwardSeptember 16, 2025 | globenewswire.comWoodline Partners LP Buys New Stake in Arcutis Biotherapeutics, Inc. $ARQTSeptember 15, 2025 | marketbeat.com20,652 Shares in Arcutis Biotherapeutics, Inc. $ARQT Bought by Invst LLCSeptember 15, 2025 | marketbeat.com36,313 Shares in Arcutis Biotherapeutics, Inc. $ARQT Purchased by Fred Alger Management LLCSeptember 13, 2025 | marketbeat.comTodd Watanabe Sells 9,625 Shares of Arcutis Biotherapeutics (NASDAQ:ARQT) StockSeptember 12, 2025 | marketbeat.comArcutis Biotherapeutics (NASDAQ:ARQT) Hits New 12-Month High - Here's WhySeptember 11, 2025 | marketbeat.comArcutis Biotherapeutics, Inc. (ARQT) Eyes Pediatric Expansion for ZORYVE CreamSeptember 11, 2025 | msn.comInsider Selling: Arcutis Biotherapeutics (NASDAQ:ARQT) Insider Sells 9,625 Shares of StockSeptember 11, 2025 | insidertrades.comArcutis Biotherapeutics (ARQT) Surges 31% In Last QuarterSeptember 10, 2025 | finance.yahoo.comArcutis Biotherapeutics (NASDAQ:ARQT) Insider Sells $583,860.80 in StockSeptember 10, 2025 | marketbeat.com55,205 Shares in Arcutis Biotherapeutics, Inc. $ARQT Purchased by Scientech Research LLCSeptember 10, 2025 | marketbeat.comArcutis Biotherapeutics Submits Supplemental New Drug Application to FDA For ZORYVESeptember 10, 2025 | insidermonkey.comArcutis Biotherapeutics, Inc. (ARQT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)September 9, 2025 | seekingalpha.comArcutis Biotherapeutics (ARQT): Is the Stock’s Quiet Rally Signaling an Undervalued Opportunity?September 9, 2025 | finance.yahoo.com22,082 Shares in Arcutis Biotherapeutics, Inc. $ARQT Bought by Ieq Capital LLCSeptember 8, 2025 | marketbeat.comArcutis Biotherapeutics, Inc. $ARQT Shares Sold by Cormorant Asset Management LPSeptember 6, 2025 | marketbeat.comArcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)September 5, 2025 | globenewswire.comArcutis Biotherapeutics (NASDAQ:ARQT) Director Howard Welgus Sells 10,000 SharesSeptember 5, 2025 | insidertrades.comArcutis Biotherapeutics sybmits sNDA for ZORYVE Cream 0.3%September 3, 2025 | msn.comArcutis Biotherapeutics, Inc. (ARQT) Presents At Citi's Biopharma Back To School Conference TranscriptSeptember 3, 2025 | seekingalpha.comArcutis Biotherapeutics Submits Application for ZORYVE Cream as First Topical Treatment for Plaque Psoriasis in Children Ages 2 and UpSeptember 3, 2025 | quiverquant.comQArcutis Submits Supplemental New Drug Application for ZORYVE® (roflumilast) Cream 0.3% to Expand Indication for Treatment of Plaque Psoriasis in Children Ages 2 to 5September 3, 2025 | globenewswire.comParadigm Biocapital Advisors LP Acquires New Position in Arcutis Biotherapeutics, Inc. $ARQTSeptember 2, 2025 | marketbeat.comRafferty Asset Management LLC Reduces Stock Position in Arcutis Biotherapeutics, Inc. $ARQTSeptember 2, 2025 | marketbeat.comJump Financial LLC Raises Stock Position in Arcutis Biotherapeutics, Inc. $ARQTSeptember 2, 2025 | marketbeat.comArcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Receives Average Rating of "Moderate Buy" from BrokeragesAugust 31, 2025 | marketbeat.comArcutis Biotherapeutics, Inc. $ARQT Shares Bought by MYDA Advisors LLCAugust 30, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Sells 18,036 Shares of Arcutis Biotherapeutics, Inc. $ARQTAugust 26, 2025 | marketbeat.com3 Biotech Catalysts Present Major Opportunity (ARQT)Three promising biotech names stand out for potentially catalyzing drugs currently on the market or in development; here's why they may rally further.August 25, 2025 | marketbeat.comAmerican Century Companies Inc. Has $25.85 Million Stake in Arcutis Biotherapeutics, Inc. $ARQTAugust 25, 2025 | marketbeat.comArcutis Biotherapeutics, Inc. $ARQT Shares Acquired by Vanguard Group Inc.August 25, 2025 | marketbeat.comArcutis Biotherapeutics, Inc. $ARQT Stock Holdings Increased by Algert Global LLCAugust 24, 2025 | marketbeat.comNuveen LLC Buys Shares of 815,816 Arcutis Biotherapeutics, Inc. $ARQTAugust 24, 2025 | marketbeat.comArcutis Biotherapeutics, Inc. $ARQT Shares Acquired by Invesco Ltd.August 23, 2025 | marketbeat.comArcutis: ZORYVE's Multi-Indication Momentum And Margin Expansion Justify A Bullish Re-RateAugust 23, 2025 | seekingalpha.comPatrick Burnett Sells 1,750 Shares of Arcutis Biotherapeutics (NASDAQ:ARQT) StockAugust 22, 2025 | insidertrades.comArcutis Biotherapeutics, Inc. $ARQT Shares Acquired by Aberdeen Group plcAugust 22, 2025 | marketbeat.comArcutis to Present at Upcoming Investor ConferencesAugust 19, 2025 | globenewswire.comAnalysts Conflicted on These Healthcare Names: GoodRx Holdings (GDRX) and Arcutis Biotherapeutics (ARQT)August 18, 2025 | theglobeandmail.comTejara Capital Ltd Has $13.24 Million Stock Holdings in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT)August 17, 2025 | marketbeat.com57,613 Shares in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Acquired by Cookson Peirce & Co. Inc.August 17, 2025 | marketbeat.comArcutis Biotherapeutics Earns Relative Strength Rating UpgradeAugust 16, 2025 | msn.comEntropy Technologies LP Purchases Shares of 15,744 Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT)August 16, 2025 | marketbeat.comInsider Selling: Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Insider Sells 3,847 Shares of StockAugust 14, 2025 | marketbeat.comInformed Momentum Co LLC Takes Position in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT)August 13, 2025 | marketbeat.com Get Arcutis Biotherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ARQT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ARQT Media Mentions By Week ARQT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ARQT News Sentiment▼1.010.73▲Average Medical News Sentiment ARQT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ARQT Articles This Week▼68▲ARQT Articles Average Week Get the Latest News and Ratings for ARQT and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Arcutis Biotherapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies GRFS News Today RYTM News Today ABVX News Today CYTK News Today LEGN News Today AXSM News Today NUVL News Today RNA News Today MRUS News Today CRSP News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ARQT) was last updated on 9/22/2025 by MarketBeat.com Staff From Our PartnersWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredWhat The Silver Boom Could Mean For You…AI, electric vehicles, and even global central banks are quietly fueling record demand for silver. This once-o...Goldco Precious Metals | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredPrepare for the “Mar-a-Lago Accord” Money ShockWhy Are Wall Street Insiders Moving Their Money to This ONE Asset? Something far more consequential for you...Stansberry Research | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arcutis Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Arcutis Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
